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Abstract
Overconsumption of sugar-sweetened beverages has been implicated in the pathogenesis of CVD. The objective of the present study was
to elucidate acute haemodynamic and microcirculatory responses to the ingestion of sugary drinks made from sucrose, glucose or fructose
at concentrations similar to those often found in commercial soft drinks. In a randomised cross-over study design, twelve young healthy
human subjects (seven men) ingested 500ml tap water in which was dissolved 60 g of either sucrose, glucose or fructose, or an amount of
fructose equivalent to that present in sucrose (i.e. 30 g fructose). Continuous cardiovascular monitoring was performed for 30min before
and at 60min after ingestion of sugary drinks, and measurements included beat-to-beat blood pressure (BP) and impedance cardiography.
Additionally, microvascular endothelial function testing was performed after iontophoresis of acetylcholine and sodium nitroprusside using
laser Doppler ﬂowmetry. Ingestion of fructose (60 or 30 g) increased diastolic and mean BP to a greater extent than the ingestion of 60 g of
either glucose or sucrose (P,0·05). Ingestion of sucrose and glucose increased cardiac output (CO; P,0·05), index of contractility
(P,0·05) and stroke volume (P,0·05), but reduced total peripheral resistance (TPR; P,0·05), which contrasts with the tendency of fruc-
tose (60 and 30 g) to increase resistance. Microvascular endothelial function did not differ in response to the ingestion of various sugary
drinks. In conclusion, ingestion of fructose, but not sucrose, increases BP in healthy human subjects. Although sucrose comprises glucose
and fructose, its changes in TPR and CO are more related to glucose than to fructose.
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Overconsumption of soft drinks is now considered to be a
major public health concern with implications for the patho-
genesis of obesity, type 2 diabetes and CVD. There is compel-
ling evidence that consumption of sugar-sweetened
beverages, as well as sugar in the form of fructose or glucose,
is associated with increased blood pressure (BP)(1). Further-
more, reduced consumption of sugar-sweetened beverages,
as well as sugars in the form of sucrose, glucose and fructose,
was found to be signiﬁcantly associated with reduced BP in a
prospective study(2).
Although several long-term and epidemiological studies
have evaluated the association between sugars and BP(1–5),
little is known about postprandial cardiovascular and haemo-
dynamic responses to sugary drinks. In healthy elderly sub-
jects, consumption of sucrose and glucose, but not fructose,
decreased BP(6), suggesting differential haemodynamic
responses to the ingested sugars. Recently, work in our
laboratory has shown that BP increased acutely after fructose,
but not glucose, ingestion in healthy young adults(7). In the
latter study, the BP response was accompanied by a substan-
tial drop in total peripheral resistance (TPR) after glucose
ingestion, which was not observed with fructose ingestion(7).
Microvascular endothelial dysfunction was found to be associ-
ated with increased BP in obese and lean women(8) as well as
in normal subjects(9). Recently, a study has found no alteration
of endothelial function after ingestion of either a glucose or
isoenergetic glucose–fructose (45:55, w/w) beverage(10), but
in this latter study, they did not measure haemodynamics,
therefore, a relationship between endothelial function and
the BP effect of sucrose, glucose and fructose is still lacking.
The purpose of the present study was to evaluate in young
and healthy adults the haemodynamic consequences of
sucrose, and its building blocks fructose and glucose ingested
separately as well as in combination. A second aim was to
*Corresponding author: E. K. Grasser, fax þ41 26300 9734, email erikkonrad.grasser@unifr.ch
Abbreviations: ACh, acetylcholine; BP, blood pressure; CO, cardiac output; DBP, diastolic blood pressure; HR, heart rate; IC, index of contractility;
MBP, mean blood pressure; SBP, systolic blood pressure; SV, stroke volume; TPR, total peripheral resistance.
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investigate microvascular endothelial function to determine
a possible relationship to the observed BP-elevating effects
of fructose.
Materials and methods
Subjects
A total of twelve healthy young adults (ﬁve women, seven
men), aged 22·0 (SE 0·4) years, were recruited from local stu-
dents and their friends. The mean height of the participants
was 175 (SE 3) cm, body weight was 66 (SE 3) kg and BMI
was 21·5 (SE 0·7) kg/m2. All of the test subjects were non-
obese with normal resting BP (brachial systolic blood pressure
(SBP)/diastolic blood pressure (DBP) ,135/85mmHg). None
of the subjects had any diseases or were taking any medi-
cation affecting cardiovascular regulation. All participants
fasted for $12 h and abstained from alcohol, smoking and
caffeine, as well as from vigorous exercise for 24 h, before
each test and were advised not to change their dietary habits
between the tests. The present study was conducted according
to the guidelines laid down on the Declaration of Helsinki,
and all procedures involving human subjects were approved
by the local ethics committee (approval no. 132005). Written
informed consent was obtained from all subjects.
Experimental design
All studies started between 08.00 and 09.00 hours in an
air-conditioned (temperature 22 ^ 18C), quiet laboratory,
with subjects at thermal comfort. Every test subject attended
four separate experimental sessions (separated by at least
3 d) according to a randomised cross-over design. Randomis-
ation was performed using a random sequence generator
(http://www.random.org/sequences/) by which the session
order was determined for twelve test subjects before the
commencement of the study. At each experimental session,
cardiovascular responses to one of four test drinks were mon-
itored. The drinks tested were as follows: (1) water containing
60 g sucrose; (2) water containing 60 g glucose; (3) water
containing 60 g fructose; (4) water containing 30 g fructose.
Each test drink also contained 10ml lemon juice (to cover par-
tially the difference in sweetness) and was made up to a total
of 500ml by addition of tap water (water temperature
22 ^ 18C). The subjects were not informed about the order
of the drinks.
On arrival at the laboratory, subjects were asked to empty
their bladders if necessary and to sit in a comfortable armchair.
All subjects wore light clothing consisting of a t-shirt and trou-
sers. The equipment was then connected and the test subject’s
upper part of the body was covered with a light blanket. After
waiting for a period (within 30min) to reach stable values for
cardiovascular functions (heart rate (HR), BP and cardiac
output (CO)), the microvascular function test was performed
(time required: approximately 32min). Cardiovascular record-
ings started immediately after the microvascular testing with
a 30min baseline period after which the subjects ingested
the test drink over a period of 4min, which was followed
by post-drink cardiovascular recordings made for 60min. At
the end of this period, the BP measuring equipment was
removed and microvascular function testing was repeated.
Throughout the procedures, subjects were allowed to watch
documentaries.
Haemodynamics
Cardiovascular recordings were performed using a Task Force
Monitor (CNSystems Medizintechnik AG) with data sampled at
a rate of 1000Hz(11). Continuous BP was monitored using the
Penaz principle from either the index or middle ﬁnger of the
right hand and was calibrated to oscillometric brachial BP
measurements on the contralateral arm. Impedance cardiogra-
phy measurements(12), in which the changes in thoracic impe-
dance are converted to reﬂect the changes in thoracic ﬂuid
content/volume over time, were performed based on the orig-
inal Kubicek et al.(13) approach but using an improved esti-
mate of thoracic volume(14), which allows calculation of
cardiac stroke volume (SV). Electrocardiogram/impedance
electrodes were positioned together with upper-arm and
Table 1. Baseline haemodynamic data recorded 30min before ingesting each of the test drinks and baseline laser Doppler
perfusion for microvascular measurements
(Mean values with their standard errors)
Fructose
(60 g)
Fructose
(30 g)
Glucose
(60 g)
Sucrose
(60 g)
Mean SE Mean SE Mean SE Mean SE
Systolic blood pressure (mmHg) 117 3 118 3 115 3 116 4
Mean blood pressure (mmHg) 89 2 91 3 88 2 88 3
Diastolic blood pressure (mmHg) 76 2 77 3 74 2 75 3
Heart rate (beats/min) 64 3 64 2 63 2 62 2
Stroke volume (ml) 81 4 80 4 82 3 85 3
Cardiac output (litres/min) 5·1 0·2 5·2 0·2 5·1 0·2 5·2 0·2
Total peripheral resistance (mmHg £ min per litre) 17·6 0·6 17·7 0·8 17·3 0·5 17·2 0·7
Index of contractility (1000/s) 54 3 55 3 56 3 57 4
Acetylcholine (PU)† 15·2 2·5 19·8 3·2 19·9 2·3 22·5 3·9
Sodium nitroprusside (PU)† 10·9 1·8 12·7 1·8 15·6 2·5 15·9 3·4
PU, perfusion units.
†Baseline skin blood ﬂux, average over the last 30 s before the ﬁrst application.
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ﬁnger BP cuffs. Electrode strips were placed at the neck and
thoracic regions, the latter speciﬁcally at the midclavicular
line at the xiphoid process level (CNSystems standard elec-
trode kits). Myocardial contractility parameters were derived
through impedance cardiography measurement(12).
Microvascular endothelial function
Microvascular endothelial function was assessed non-inva-
sively in the ﬁnger-skin microcirculation by a combination
of iontophoresis and laser Doppler ﬂowmetry (Perimed
PF5010; Ja¨rfa¨lla), using a standard protocol(15).
Acetylcholine (ACh, 1%, Fluka; Sigma-Aldrich Chemie
GmbH) was delivered to the middle dorsal phalanx of the
third ﬁnger of the non-dominant hand using an anodal electri-
cal current, consisted of seven doses (0·1mA for 20 s) with a
60 s interval between each dose. The electrical current was
conveyed by a battery power supply that was isolated from
the mains electricity. Then, sodium nitroprusside (0·01%,
Riedel-de Haen; Sigma-Aldrich Laborchemikalien GmbH)
was delivered to the same spot of the fourth ﬁnger using a
cathodal current, consisted of nine doses (0·2mA for 20 s)
with a 90 s interval between each dose. Skin perfusion
responses were recorded by a laser Doppler ﬂowmetry
probe (in perfusion units), and the temperature of the probe
was kept constant at 328C during all measurements. The pro-
tocol was chosen because it is sufﬁcient to provide effective
ACh and sodium nitroprusside delivery but avoids non-
speciﬁc vasodilation observed with higher electrical
charges(16). CV for the maximum response to ACh was 31
(SE 5)% and to sodium nitroprusside was 40 (SE 5)%, deter-
mined from all pre-drink tests, which is in agreement with a
previous study(17).
Data and statistical analysis
The present sample size is based on variability estimates for
BP (our primary outcome) obtained from our previous exper-
iments(7). Power analysis, with type I error (a) of 0·05 and
a desired power (1 2 b) of 0·80, suggests that for such an
investigation of repeated measures (on the same subject),
a total number of twelve subjects would be required.
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Fig. 1. Time course for changes in systolic blood pressure (SBP) (a) and diastolic blood pressure (DBP) (b) before and after ingestion of fructose ( ), fructose at
30 g (fructose 30; ), glucose ( ) and sucrose ( ). Time 0 indicates the resumption of the recordings after the 4min drink period. Values are means, with their
standard errors represented by vertical bars. Mean value was signiﬁcantly different from that at baseline over time: *P,0·05, **P,0·01, ***P,0·005. Mean
value was signiﬁcantly different from that of the sucrose drink (equivalent to the AUC): †P,0·05, ††P,0·01. ‡‡Mean value was signiﬁcantly different from that
of the glucose drink (equivalent to the AUC) (P,0·01).
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Assumptions employed in the power analysis of the present
study for BP, our most relevant variable, include the following:
(1) standard deviation (s) of the difference in post-drink
BP response of 5mmHg; (2) physiologically and clinically
relevant difference (d) in post-drink BP change of 5mmHg.
Values of cardiac interval, BP (SBP, mean blood pressure
(MBP) and DBP), cardiac SV and index of contractility (IC)
were averaged every 15min during the baseline period and
over the 1 h post-drink period. CO was derived as the product
of SV and HR. TPR was calculated as MBP divided by CO,
whereas MBP was calculated from DBP and SBP, respectively:
MBP ¼ DBPþ 1=3ðSBP2 DBPÞ:
The IC reﬂects the aortic peak ﬂow and it is the maximum
impedance changes (DZ divided by Dtmax) normalised to the
ground impedance Z0. Maximal increase in skin perfusion
was computed as the average of the last two stimuli minus
baseline.
All values are reported as means with their standard errors.
Statistical analysis was performed by two-way ANOVA for
repeated measures with time (0, 15, 30, 45 and 60min) and
treatment – sucrose (60 g), glucose (60 g), fructose (60 g)
and fructose (30 g) – as within-subject factors using statistical
software (Statistix version 8.0; Analytical Software). Where sig-
niﬁcant differences were found, the effects of each drink over
time were analysed by comparing the values at each time
point over the post-drink period with the baseline values
recorded during the 30min period immediately before drink-
ing. One-way ANOVA with Dunnett’s multiple comparison test
and repeated-measures ANOVA with the Newman–Keuls
post hoc test were used to determine the changes over time
from baseline levels and to compare mean changes between
the drink types. A paired t test was used to compare mean
changes from baseline over 60min for each drink, respect-
ively. A Friedman test with Dunn’s post hoc testing was used
to compare vasodilatory responses before and after drug
administration. All reported P values are two-sided. For all
tests, signiﬁcance was set at P#0·05.
Results
Cardiovascular responses to the sugary drinks
Resting values were similar for both haemodynamic and
microvascular measurement parameters (Table 1). None of
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Fig. 2. Time course for changes in mean blood pressure (MBP) (a) and heart rate (HR) (b) before and after ingestion of fructose ( ), fructose at 30g (fructose 30; ),
glucose ( ) and sucrose ( ). Time 0 indicates the resumption of the recordings after the 4min drink period. Values are means, with their standard errors represented
by vertical bars. Mean value was signiﬁcantly different from that at baseline over time: *P,0·05, **P,0·01, ***P,0·005. Mean value was signiﬁcantly different from
that of the glucose drink (equivalent to the AUC): †P,0·05, ††P,0·01. ‡‡Mean value was signiﬁcantly different from that of the sucrose drink (equivalent to the AUC)
(P,0·01).
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the test subjects reported nausea or other unpleasant effects
after ingesting the test drinks.
Figs. 1 and 2 show the changes in SBP, DBP, MBP and HR
after ingesting the various test drinks. Signiﬁcant effects for
time (SBP: P,0·005; DBP: P,0·005; MBP: P,0·005; HR:
P,0·005), drink (SBP: P,0·05; DBP: P,0·01; MBP:
P,0·005) and drink £ time interaction (SBP: P,0·05; DBP:
P,0·01; MBP: P,0·01; HR: P,0·05) were found for SBP,
DBP, MBP and HR. Ingestion of fructose (60 or 30 g) led to sig-
niﬁcant elevation in SBP, DBP and MBP over time starting
approximately 30min after ingestion (peak fructose 60 g for
SBP: 7·1mmHg, P,0·005; DBP: 5·6mmHg, P,0·005; MBP:
6·1mmHg, P,0·005; peak fructose 30 g for SBP: 5·4mmHg,
P,0·005; DBP: 4·0mmHg, P,0·005; MBP: 4·3mmHg,
P,0·005). Ingestion of glucose led to increased SBP
(2·5mmHg, P,0·05) over time, whereas ingestion of sucrose
showed no changes related to BP (Figs. 1 and 2). Comparison
of the responses to the ingested test drinks (mean change
from baseline levels) showed that the increases in DBP and
MBP were signiﬁcantly higher for fructose (60 or 30 g) than
for either glucose or sucrose (Figs. 1 and 2). For SBP, there
was a signiﬁcant difference found between fructose and
sucrose (Fig. 1(a)). The fructose 30 g drink decreased HR sig-
niﬁcantly within the ﬁrst 15min after ingestion followed by a
steady increase, at which a similar time course to that of the
fructose 60 g drink was observed. The HR response over
time for glucose and sucrose resulted, after a small initial
drop, in a gradual increase for sucrose but not for glucose.
A comparison between the test drinks showed no signiﬁcant
differences in changes from baseline levels (Fig. 2(b)).
Figs. 3 and 4 show the changes over time and the mean
changes from baseline levels for CO, TPR, SV and IC. Signiﬁ-
cant effects for time (CO: P,0·005; TPR: P,0·01; SV:
P,0·005; IC: P,0·005), drink (CO: P,0·005; TPR: P,0·005;
SV: P,0·05; IC: P,0·05) and drink £ time interaction (CO:
P,0·01; TPR: P,0·005; SV: P,0·005; IC: P,0·005) were
found for CO, TPR, SV and IC. All sugars increased CO, but
only glucose and sucrose showed signiﬁcant changes over
time (peak for glucose: 0·54 litres/min, P,0·005; peak for
sucrose: 0·51 litres/min, P,0·005). Glucose and sucrose
showed signiﬁcantly higher CO compared with fructose
(60 or 30 g) (Fig. 3(a)). Comparison of changes over time
indicates that TPR is slightly, but not signiﬁcantly, increased
with the ingestion of fructose (60 and 30 g) but decreased
signiﬁcantly with the ingestion of glucose and sucrose (peak
for glucose: 21·18mmHg £ min per litre, P,0·01; peak for
sucrose: 21·45mmHg £ min per litre, P,0·005). TPR for fruc-
tose (60 or 30 g) is signiﬁcantly higher than that for glucose or
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Fig. 3. Time course for changes in cardiac output (CO) (a) and total peripheral resistance (TPR) (b) before and after ingestion of fructose ( ), fructose at 30 g
(fructose 30; ), glucose ( ) and sucrose ( ). Time 0 indicates the resumption of the recordings after the 4min drink period. Values are means, with their stan-
dard errors represented by vertical bars. Mean value was signiﬁcantly different from that at baseline over time: *P,0·05, **P,0·01, ***P,0·005. ††Mean value
was signiﬁcantly different from that of the fructose drink (equivalent to the AUC) (P,0·01). Mean value was signiﬁcantly different from that of the fructose 30 drink
(equivalent to the AUC): ‡‡P,0·01, ‡‡‡P,0·005. §§§Mean value was signiﬁcantly different from that of the sucrose drink (equivalent to the AUC) (P,0·005).
kkkMean value was signiﬁcantly different from that of the glucose drink (equivalent to the AUC) (P,0·005).
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sucrose (Fig. 3(b)). In contrast to fructose, sucrose and glucose
increased SV and IC signiﬁcantly over time (SV peak for
sucrose: 5·3ml, P,0·005; glucose: 7·0ml, P,0·005; IC peak
for sucrose: 4·5 £ 1000 per s, P,0·005; glucose: 5·7 £ 1000
per s, P,0·005; Fig. 4(a) and (b)). Ingestion of glucose
increased SV more than the ingestion of fructose (60 and
30 g), whereas the IC was found to be higher with the inges-
tion of glucose and sucrose than with the ingestion of both
fructose drinks (Fig. 4(a) and (b)).
Microvascular function
There were no signiﬁcant differences observed for ACh- and
sodium nitroprusside-mediated microvascular endothelial
ﬂux between fructose, glucose and sucrose. Although, com-
pared with pre-drink values, a tendency for fructose at 30 g
to increase ACh-mediated vasodilation was observed (80
(SE 19) v. 103 (SE 17) arbitrary units, P ¼ 0·08; Table 2),
these differences did not reach statistical signiﬁcance.
Discussion
To our knowledge, this is the ﬁrst study using beat-to-beat
cardiovascular measurements to evaluate haemodynamic
consequences after ingestion of sucrose and its building
blocks glucose and fructose at isoenergetic amounts, and at
an amount of fructose equivalent to that present in sucrose
(i.e. 30 g fructose). The results of the present study demon-
strate that sucrose ingestion does not mimic the BP-elevating
effect of fructose, independently of whether sucrose is com-
pared with fructose at isoenergetic amounts (60 g each) or
with fructose at an amount equivalent to that present in
sucrose (30 g fructose v. 60 g sucrose); the haemodynamic
responses and BP-elevating effects of fructose being similar
whether provided as 60 g or as 30 g, and higher than with
60 g of either sucrose or glucose. Furthermore, the present
study indicates no differences in haemodynamic responses
to sucrose and glucose ingestion, and no differences in micro-
vascular endothelial function in response to the various sugars
ingested (glucose, fructose and sucrose). Taken together, the
present results indicate that the glucose component of sucrose
attenuates the acute fructose-induced elevation of BP in young
and healthy human subjects.
Studies for the BP response to orally ingested sucrose in
healthy human subjects are scarce. We chose the sugar content
as 60 g (in 500ml water) for the present study on the basis that
this amount is commonly available in soft drinks, thereby
mimicking a daily-life scenario. SBP increased with ingestion
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of all sugars in the present study, with fructose showing
the highest response (5–6 v. 1-3mmHg for the other sugars).
Furthermore, whereas ingestion of sucrose and glucose
caused only a marginal or no change in DBP, ingestion of
fructose increased DBP substantially (3–5mmHg between 30
and 60min post-drink). These results are consistent with our
previous ﬁndings(7) for an elevated DBP value up to 120min
after ingestion of fructose but not after ingestion of glucose.
Our ﬁndings, however, differ from Rebello et al.(18) who
reported SBP to be elevated with sucrose and glucose but
not with fructose 1 h after ingestion, and, furthermore, with
no effect on DBP. In this latter study, the response to fructose
should be interpreted with caution because all of their subjects
experienced watery diarrhoea after ingestion of fructose
(1 g/kg), most of them within 40 and 60min post-drink.
Furthermore, unlike in the present study in which we per-
formed continuous measurement of BP, Rebello et al.(18)
used a discontinuous oscillometric method to measure BP
values. Another study by Visvanathan et al.(6) in elderly
healthy individuals (72 years old on average) found SBP and
DBP to be decreased after ingesting 50 g of either sucrose or
glucose, whereas fructose ingestion showed no such decrease.
Similarly, BP has been reported to fall slightly after ingestion
of 75 g glucose but not after ingesting the same amount of
fructose in elderly normotensive subjects(19).
A likely explanation for the discrepancy between the
blunted BP response after ingestion of sucrose (60 g) and its
elevation after ingesting either isoenergetic (60 g) or equival-
ent (30 g) amounts of fructose can be derived by the actions
of insulin. The observation of an increase in SV and CO and
a decrease in TPR with ingestion of sucrose and glucose but
not with ingestion of fructose in the present study is likely
due to the action of insulin because insulin is known to
increase dose-dependently CO by rising SV and HR and to
decrease systemic vascular resistance(20). In the present
study, the rise of CO with ingestion of glucose and sucrose
was secondary due to an increase in SV with minor changes
in HR, whereas fructose did not affect CO and SV. In contrast,
ingestion of glucose and sucrose substantially decreased TPR,
whereas a small increase in TPR was found after ingestion of
fructose. Therefore, it is likely that the actions of insulin were
at least partly responsible for the aforementioned ﬁndings.
Moreover, the differences for TPR in response to the ingestion
of sugars in the present study fully account for the BP results.
It can be speculated that the observed positive inotropy
with glucose and sucrose but not fructose consumption
could partly explain the accompanying rise in SV in the pre-
sent study. Using radionuclide ventriculography, Fisher
et al.(21) observed an immediate increase in inotropy in
response to intravenous injection of insulin. In vitro exper-
iments on human atrial myocardium found positive inotropic
effects in response to insulin(22). However, the failure of two
studies to ﬁnd changes in inotropy in healthy human subjects
after intravenous administration of insulin(23,24) calls for cau-
tion in attributing the observed inotropy with glucose or
sucrose consumption to changes in insulin alone.
We conducted microvascular endothelial function testing to
investigate whether changes in BP following ingestion of
sugary drinks are linked to endothelial dysfunction. Here,
we found a trend (P¼0·08) towards an augmentation of endo-
thelial function after ingestion of 30 g fructose with a non-sig-
niﬁcant increase after ingestion of fructose and sucrose.
Ingestion of glucose resulted in a non-signiﬁcant attenuation
in ACh-mediated vasodilation. Bidwell et al.(10) assessed endo-
thelial function using forearm blood ﬂow measurements com-
bined with reactive hyperaemia after acute ingestion of either
a glucose or isoenergetic glucose–fructose (45:55, w/w)
beverage and found no signiﬁcant alterations in endothelial
function. In line with the present results, they observed,
60min after ingestion, a small non-signiﬁcant difference
between the glucose–fructose and glucose beverages(10), but
the former tended to be higher. Based on the results, a contri-
bution of microvascular endothelial function to the increase in
BP after ingestion of fructose seems unlikely.
There are limitations in the present study. First, we cannot
rule out the possibility that differences in perceived sweetness
between the test drinks could have inﬂuenced the present
results. However, we believe that the addition of 10ml
lemon juice to each drink minimised these differences in
sweetness perception. Second, the primary focus of the
Table 2. Microvascular endothelial function measurements before (pre-drink*) and after (post-
drink*) the ingestion of fructose at 60 g, fructose at 30 g, glucose at 60 g and sucrose at 60 g
(Mean values with their standard errors)
Fructose
(60 g)
Fructose
(30 g)
Glucose
(60 g)
Sucrose
(60 g)
Mean SE Mean SE Mean SE Mean SE
DACh-mediated vasodilation
Pre-drink (PU) 70 20 80 19 87 19 69 13
Post-drink (PU) 96 19 103 17 73 23 80 16
P 0·2 0·08 0·47 0·49
DSNP-mediated vasodilation
Pre-drink (PU) 78 22 76 17 72 12 75 16
Post-drink (PU) 91 21 91 15 94 12 72 9
P 0·65 0·3 0·13 0·86
ACh, acetylcholine; PU, perfusion units; SNP, sodium nitroprusside.
* Pre- and post-drink conditions were compared using either a paired t test or a Wilcoxon signed-rank test.
P,0·05 was considered as statistically signiﬁcant.
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Table 3. Summary of the studies in which plasma insulin and glucose levels were reported before and at 60min after ingestion of a sugary drink or a sugared ﬂuid meal in healthy human subjects*
Study Sugar type
Baseline plasma
insulin level
(mU/ml)
Baseline plasma
glucose level
(mmol/l)
DPlasma
insulin level
(mU/ml)
DPlasma
glucose level
(mmol/l) Study details
1. Blaak et al.(26)† Glucose (75 g) 9 4·8 44 1·3 Ten males; response to the ingestion of 400ml lemon-ﬂavoured water
containing 75 g of either glucose, fructose or sucrose
Sucrose (75 g) 9 4·8 23 0·8
Fructose (75 g) 9 4·8 7 0·1
2. Rebello et al.(18)† Glucose (1 g/kg BW) 22 4·4 73 1·7 Twenty young men; randomised cross-over design; response to the
ingestion of glucose, sucrose or fructose dissolved in water
Sucrose (1 g/kg BW) 19 4·5 63 1·1
Fructose (1 g/kg BW) 29 4·4 7 0·2
3. Chong et al.(27)‡ Glucose (0·75 g/kg BW) 8·6§ 5 45§ 2·2 Fourteen subjects; randomised cross-over design; response to the
ingestion of a fructose or glucose test meal
Fructose (0·75 g/kg BW) 8·6§ 5 7§ 0·4
4. Fukagawa et al.(28)† Glucose (75 g) 5 4·4§ 60 3·2§ Eight young subjects; response to the ingestion of 500ml lemon-
ﬂavoured water containing 75 g of either glucose or fructose
Fructose (75 g) 5 4·4§ 12 0·9§
5. Mu¨nstedt et al.(29)† Glucose (75 g) 4·5 5·1§ 45 1·0§ Fifteen young males; serum levels of glucose, fructose and insulin were
investigated comparing honey types
Fructose (75 g) 6·5 4·1§ 10 0·7§
6. Schwarz et al.(30)‡ Glucose (75 g) 12§ 4·8 95§ 2·6 Twenty young adults; randomised cross-over design; response to the
ingestion of a 200–300ml ﬂuid meal containing 75 g of either glucose
or fructose (2498 kJ (597 kcal))
Fructose (75 g) 12§ 4·8 22§ 0·4
7. Tappy et al.(31)† Glucose (75 g) 9 5·1§ 50 3·8§ Ten volunteers; randomised cross-over design; response to the
ingestion of 300ml lemon-ﬂavoured water containing 75 g of either
glucose or fructose
Fructose (75 g) 9 5·1§ 10 0·9§
BW, body weight.
* Values for plasma insulin and glucose levels were either obtained from tables (Rebello et al.(18) and Mu¨nstedt et al.(29)) or estimated from ﬁgures (Blaak et al.(26), Chong et al.(27), Fukagawa et al.(28), Schwarz et al.(30) and Tappy
et al.(31)).
† Studies with sugary drinks.
‡Studies with sugared ﬂuid drinks.
§Values were originally expressed as mU/ml (Blaak et al. (26), Rebello et al. (18), Fukagawa et al. (28), Mu¨nstedt et al. (29) and Tappy et al. (31)) or as pmol/l (Chong et al. (27) and Schwarz et al. (30)) for plasma insulin or as mmol/l
(Blaak et al. (26), Rebello et al. (18), Chong et al. (27) and Schwarz et al. (30)) and as mg/dl (Fukagawa et al. (28), Mu¨nstedt et al. (29) and Tappy et al. (31)) for plasma glucose. A conversion factor of 0·166 was used to convert pmol/l
to mU/ml and 0·0555 to convert mg/dl to mmol/l.
8
ht
tp
://
do
c.
re
ro
.c
h
present study was on BP responses for which a power analysis
indicated that a sample size of twelve subjects would be
required to identify signiﬁcant differences. However, the part
of the present study assessing microvascular endothelial func-
tions may not be sufﬁciently powered because of the large
inherent variability in the measurements of microvascular
functions. Consequently, our ﬁndings that there are no signiﬁ-
cant differences across the various drinks for these secondary
outcome parameters should be taken with caution. Third, we
did not measure insulin concentrations because we wanted to
avoid taking blood samples that could inﬂuence subtle
haemodynamic changes pertaining to venous cannulation(25).
Furthermore, based on a literature search, we found compelling
evidence that a sugary drink or a sugared ﬂuid meal at compar-
able amounts to those used in the present study raises plasma
insulin and glucose levels substantially (Table 3) (18,26–31).
Using a hyperinsulinaemic clamp approach in healthy
human subjects, a recent study has found an improvement
in skin and skeletal muscle microvasculature perfusion in
response to reactive hyperaemia, suggesting that insulin inﬂu-
ences the microvasculature from the skin and skeletal muscle
similarly(15). Therefore, in the present study, it seems plausible
to refer the observed cardiovascular consequences after inges-
tion of glucose and sucrose at least partly to insulin.
In conclusion, ingestion of a sugary drink containing 60 g
sucrose seems unlikely to have an impact on BP in healthy
young human subjects while isoenergetic amounts of fructose
raised the BP substantially. Although sucrose comprises
equivalent amounts of glucose and fructose, changes in TPR
and CO are more related to glucose than to fructose. This is
the ﬁrst study to demonstrate that the BP-elevating effects of
fructose are attenuated in the presence of glucose through a
reduction in TPR.
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